MAS
63
3
D
45
4
TRIP
52
2
UPS
40
2
SO
53
5
PLD
33
3
IBM
67
2
ETR
52
3
PHM
43
2
ALLE
48
2
EQT
51
-5
SPG
53
2
AN
52
2
GS
78
2
MTB
75
2
MMC
60
3
DTE
42
4
CRM
59
-11
MCD
46
4
GRMN
40
3
MAS
63
3
D
45
4
TRIP
52
2
UPS
40
2
SO
53
5
PLD
33
3
IBM
67
2
ETR
52
3
PHM
43
2
ALLE
48
2
EQT
51
-5
SPG
53
2
AN
52
2
GS
78
2
MTB
75
2
MMC
60
3
DTE
42
4
CRM
59
-11
MCD
46
4
GRMN
40
3
Financhill
Back

VanEck Junior Gold Miners ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
84

GDXJ
VanEck Junior Gold Miners ETF

Last Price:
$120.97
Seasonality Move:
5.49%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.7200
Seasonality Move:
33.23%
Buy
84
VanEck Junior Gold Miners ETF (GDXJ) is a Buy

Is VanEck Junior Gold Miners ETF a Buy, Sell or Hold?

  • The current VanEck Junior Gold Miners ETF [GDXJ] share price is $118.97. The Score for GDXJ is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • GDXJ is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GDXJ Stock Price Chart

What is VanEck Junior Gold Miners ETF's stock price today?

  • The VanEck Junior Gold Miners ETF share price today is $118.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDXJ is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

GDXJ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.94 Buy
Relative Strength Index (14 RSI): 69.78 Buy
Chaikin Money Flow: 1664144 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.49 - 115.31) Buy
Bollinger Bands (100): (80.32 - 106.98) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

GDXJ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 115.69 Buy
20-day SMA: 110.77 Buy
50-day SMA: 102.39 Buy
200-day SMA: 78.28 Buy
8-day EMA: 115.9 Buy
20-day EMA: 111.02 Buy
50-day EMA: 102.61 Buy
200-day EMA: 61.99 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

VanEck Junior Gold Miners ETF Earnings Growth & GDXJ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

VanEck Junior Gold Miners ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):